Latest Breaking News On - Niowave chief executive - Page 1 : comparemela.com

/PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as.

United statesDenise bouckeJohn valliantTerry grimmAmanda crayFusion pharmaceuticals incMcmaster universityNiowave incNational nuclear security administrationHuman resources administrationUs department of energyFusion pharmaceuticalsPrnewswire fusion pharmaceuticals incInvestor relations corporate communicationsFusion chief executive officer john valliantNiowave chief executive